We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.89%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$16.7B
AUM Growth
+$10.2M
(+0.06%)
Cap. Flow
-$510M
Cap. Flow
% of AUM
-3.05%
Top 10 Holdings %
Top 10 Hldgs %
20.67%
Holding
1,686
New
28
Increased
245
Reduced
1,348
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$22.8M |
| 2 |
Cardinal Health
CAH
|
+$16.4M |
| 3 |
Hormel Foods
HRL
|
+$16.3M |
| 4 |
Pentair
PNR
|
+$15.9M |
| 5 |
AbbVie
ABBV
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$70.1M |
| 2 |
Microsoft
MSFT
|
+$56.8M |
| 3 |
Amazon
AMZN
|
+$50.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$24.3M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.86% |
| 2 | Financials | 13.33% |
| 3 | Healthcare | 11.75% |
| 4 | Industrials | 10.99% |
| 5 | Consumer Staples | 10.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRKL
1476
DELISTED
Brookline Bancorp
BRKL
| $164K | ﹤0.01% |
10,662
-226
| -2% | -$3.37K |
|
1477
Helix Energy Solutions
HLX
$1.46B
| $163K | ﹤0.01% |
18,927
-399
| -2% | -$3.1K |
|
1478
MediciNova
MNOV
$65M
| $162K | ﹤0.01% |
16,793
-1,867
| -10% | -$19.7K |
|
|
SRCI
1479
DELISTED
SRC Energy Inc
SRCI
| $162K | ﹤0.01% |
32,620
-692
| -2% | -$3.77K |
|
1480
Mueller Water Products
MWA
$3.93B
| $161K | ﹤0.01% |
16,388
-434
| -3% | -$4.33K |
|
|
MNK
1481
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $161K | ﹤0.01% |
17,558
-1,842
| -9% | -$26.6K |
|
|
INN
1482
Summit Hotel Properties
INN
$763M
| $160K | ﹤0.01% |
13,971
-292
| -2% | -$3.44K |
|
1483
Laureate Education
LAUR
$5.15B
| $158K | ﹤0.01% |
10,045
-265
| -3% | -$4.22K |
|
|
PDLI
1484
DELISTED
PDL BioPharma, Inc.
PDLI
| $157K | ﹤0.01% |
50,043
-15,134
| -23% | -$49.1K |
|
1485
Replimune Group
REPL
$836M
| $154K | ﹤0.01% |
10,474
-1,551
| -13% | -$22.4K |
|
1486
Element Solutions
ESI
$9.34B
| $153K | ﹤0.01% |
14,812
+499
| +3% | +$5.25K |
|
|
ODP
1487
DELISTED
ODP
ODP
| $153K | ﹤0.01% |
7,413
-163
| -2% | -$3.69K |
|
|
ACOR
1488
DELISTED
Acorda Therapeutics
ACOR
| $152K | ﹤0.01% |
165
-19
| -10% | -$23.3K |
|
|
GPOR
1489
DELISTED
Gulfport Energy Corp.
GPOR
| $152K | ﹤0.01% |
30,884
-1,407
| -4% | -$8.97K |
|
|
TWNK
1490
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $151K | ﹤0.01% |
10,459
-276
| -3% | -$3.7K |
|
1491
Corcept Therapeutics
CORT
$10.3B
| $149K | ﹤0.01% |
13,350
-277
| -2% | -$3.09K |
|
|
ADAM
1492
Adamas Trust
ADAM
$783M
| $149K | ﹤0.01% |
6,002
+40
| +0.7% | +$988 |
|
|
ACHN
1493
DELISTED
Achillion Pharmaceuticals
ACHN
| $147K | ﹤0.01% |
54,889
-6,984
| -11% | -$20.6K |
|
|
SEMG
1494
DELISTED
SEMGROUP CORPORATION
SEMG
| $146K | ﹤0.01% |
12,129
-482
| -4% | -$6.39K |
|
|
UBX
1495
DELISTED
Unity Biotechnology
UBX
| $144K | ﹤0.01% |
1,516
-192
| -11% | -$16.3K |
|
|
AMAG
1496
DELISTED
AMAG Pharmaceuticals
AMAG
| $144K | ﹤0.01% |
14,450
-2,036
| -12% | -$22K |
|
1497
Newmark Group
NMRK
$2.77B
| $142K | ﹤0.01% |
15,829
-417
| -3% | -$3.51K |
|
1498
Independence Realty Trust
IRT
$3.89B
| $139K | ﹤0.01% |
12,033
-235
| -2% | -$2.58K |
|
|
SYRS
1499
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $139K | ﹤0.01% |
1,506
+88
| +6% | +$6.13K |
|
|
LTHM
1500
DELISTED
Livent Corporation
LTHM
| $139K | ﹤0.01% |
20,024
-428
| -2% | -$3.84K |
|
Similar funds
ProShare Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, ProShare Advisors held 1,686 positions worth $16.7B, up 0.06% from $16.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
ProShare Advisors withdrew a net $510M in Q2 2019, closing 61 positions and reducing 1,348 holdings. Its most notable exit was Bemis, an estimated $12.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, ProShare Advisors opened a new position in Dow Inc worth $13.3M.
- ProShare Advisors's largest Q2 2019 buy was Dow Inc: 269,509 shares worth $13.3M.
- ProShare Advisors added most to Walgreens Boots Alliance in Q2 2019, an estimated $22.8M increase.
- ProShare Advisors's biggest Q2 2019 reduction was Apple, cutting an estimated $70.1M.
- ProShare Advisors fully exited Bemis in Q2 2019, selling an estimated $12.7M.
- ProShare Advisors's ten largest holdings make up 21% of its $16.7B portfolio in Q2 2019.
- ProShare Advisors opened 28 new positions and closed 61 in Q2 2019.
- ProShare Advisors's portfolio value rose 0.06% quarter-over-quarter to $16.7B.
Based on ProShare Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.